Cargando…

Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms

Fucoidan is a natural derived compound found in different species of brown algae and in some animals, that has gained attention for its anticancer properties. However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, an...

Descripción completa

Detalles Bibliográficos
Autores principales: van Weelden, Geert, Bobiński, Marcin, Okła, Karolina, van Weelden, Willem Jan, Romano, Andrea, Pijnenborg, Johanna M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356449/
https://www.ncbi.nlm.nih.gov/pubmed/30621045
http://dx.doi.org/10.3390/md17010032
_version_ 1783391544275894272
author van Weelden, Geert
Bobiński, Marcin
Okła, Karolina
van Weelden, Willem Jan
Romano, Andrea
Pijnenborg, Johanna M. A.
author_facet van Weelden, Geert
Bobiński, Marcin
Okła, Karolina
van Weelden, Willem Jan
Romano, Andrea
Pijnenborg, Johanna M. A.
author_sort van Weelden, Geert
collection PubMed
description Fucoidan is a natural derived compound found in different species of brown algae and in some animals, that has gained attention for its anticancer properties. However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, and all known different pathways affected by fucoidan, in order to formulate fucoidans structure and activity in relation to its anti-cancer mechanisms. The general bioactivity of fucoidan is difficult to establish due to factors like species-related structural diversity, growth conditions, and the extraction method. The main pathways influenced by fucoidan are the PI3K/AKT, the MAPK pathway, and the caspase pathway. PTEN seems to be important in the fucoidan-mediated effect on the AKT pathway. Furthermore, the interaction with VEGF, BMP, TGF-β, and estrogen receptors are discussed. Also, fucoidan as an adjunct seems to have beneficial effects, for both the enhanced effectiveness of chemotherapy and reduced toxicity in healthy cells. In conclusion, the multipotent character of fucoidan is promising in future anti-cancer treatment. However, there is a need for more specified studies of the structure–activity relationship of fucoidan from the most promising seaweed species.
format Online
Article
Text
id pubmed-6356449
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63564492019-02-05 Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms van Weelden, Geert Bobiński, Marcin Okła, Karolina van Weelden, Willem Jan Romano, Andrea Pijnenborg, Johanna M. A. Mar Drugs Review Fucoidan is a natural derived compound found in different species of brown algae and in some animals, that has gained attention for its anticancer properties. However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, and all known different pathways affected by fucoidan, in order to formulate fucoidans structure and activity in relation to its anti-cancer mechanisms. The general bioactivity of fucoidan is difficult to establish due to factors like species-related structural diversity, growth conditions, and the extraction method. The main pathways influenced by fucoidan are the PI3K/AKT, the MAPK pathway, and the caspase pathway. PTEN seems to be important in the fucoidan-mediated effect on the AKT pathway. Furthermore, the interaction with VEGF, BMP, TGF-β, and estrogen receptors are discussed. Also, fucoidan as an adjunct seems to have beneficial effects, for both the enhanced effectiveness of chemotherapy and reduced toxicity in healthy cells. In conclusion, the multipotent character of fucoidan is promising in future anti-cancer treatment. However, there is a need for more specified studies of the structure–activity relationship of fucoidan from the most promising seaweed species. MDPI 2019-01-07 /pmc/articles/PMC6356449/ /pubmed/30621045 http://dx.doi.org/10.3390/md17010032 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
van Weelden, Geert
Bobiński, Marcin
Okła, Karolina
van Weelden, Willem Jan
Romano, Andrea
Pijnenborg, Johanna M. A.
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
title Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
title_full Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
title_fullStr Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
title_full_unstemmed Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
title_short Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
title_sort fucoidan structure and activity in relation to anti-cancer mechanisms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356449/
https://www.ncbi.nlm.nih.gov/pubmed/30621045
http://dx.doi.org/10.3390/md17010032
work_keys_str_mv AT vanweeldengeert fucoidanstructureandactivityinrelationtoanticancermechanisms
AT bobinskimarcin fucoidanstructureandactivityinrelationtoanticancermechanisms
AT okłakarolina fucoidanstructureandactivityinrelationtoanticancermechanisms
AT vanweeldenwillemjan fucoidanstructureandactivityinrelationtoanticancermechanisms
AT romanoandrea fucoidanstructureandactivityinrelationtoanticancermechanisms
AT pijnenborgjohannama fucoidanstructureandactivityinrelationtoanticancermechanisms